Fresenius SE Operating Income 2016-2024 | FSNUY
Fresenius SE operating income from 2016 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Fresenius SE Annual Operating Income
(Millions of US $) |
| 2023 |
$1,237 |
| 2022 |
$3,499 |
| 2021 |
$4,919 |
| 2020 |
$5,009 |
| 2019 |
$5,187 |
| 2018 |
$6,201 |
| 2017 |
$5,187 |
| 2016 |
$4,788 |
| 2015 |
$4,303 |
Fresenius SE Quarterly Operating Income
(Millions of US $) |
| 2024-09-30 |
$541 |
| 2024-06-30 |
$284 |
| 2024-03-31 |
$607 |
| 2023-12-31 |
$-576 |
| 2023-09-30 |
$377 |
| 2023-06-30 |
$592 |
| 2023-03-31 |
$845 |
| 2022-12-31 |
$694 |
| 2022-09-30 |
$893 |
| 2022-06-30 |
$899 |
| 2022-03-31 |
$1,012 |
| 2021-12-31 |
$1,288 |
| 2021-09-30 |
$1,189 |
| 2021-06-30 |
$1,230 |
| 2021-03-31 |
$1,213 |
| 2020-12-31 |
$1,230 |
| 2020-09-30 |
$1,301 |
| 2020-06-30 |
$1,237 |
| 2020-03-31 |
$1,241 |
| 2019-12-31 |
$1,408 |
| 2019-09-30 |
$1,255 |
| 2019-06-30 |
$1,257 |
| 2019-03-31 |
$1,266 |
| 2018-12-31 |
$1,400 |
| 2018-09-30 |
$1,210 |
| 2018-06-30 |
$2,317 |
| 2018-03-31 |
$1,273 |
| 2017-12-31 |
$1,298 |
| 2017-09-30 |
$1,309 |
| 2017-06-30 |
$1,284 |
| 2017-03-31 |
$1,296 |
| 2016-12-31 |
$1,346 |
| 2016-09-30 |
$1,197 |
| 2016-06-30 |
$1,187 |
| 2016-03-31 |
$1,058 |
| 2015-12-31 |
$7,951 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.000B |
$23.628B |
|
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
|
